Flora Growth (FRA:7301) Retained Earnings : €-151.02 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Flora Growth Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Flora Growth's retained earnings for the quarter that ended in Dec. 2024 was €-151.02 Mil.

Flora Growth's quarterly retained earnings increased from Jun. 2024 (€-137.71 Mil) to Sep. 2024 (€-136.96 Mil) but then declined from Sep. 2024 (€-136.96 Mil) to Dec. 2024 (€-151.02 Mil).

Flora Growth's annual retained earnings declined from Dec. 2022 (€-85.78 Mil) to Dec. 2023 (€-130.72 Mil) and declined from Dec. 2023 (€-130.72 Mil) to Dec. 2024 (€-151.02 Mil).

Flora Growth Retained Earnings Historical Data

The historical data trend for Flora Growth's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Flora Growth Retained Earnings Chart

Flora Growth Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Retained Earnings

Get a 7-Day Free Trial

-14.21

-34.10

-85.78

-130.72

-151.02

Flora Growth Quarterly Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Retained Earnings	Get a 7-Day Free Trial														-130.72	-133.97	-137.71	-136.96	-151.02

Flora Growth Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Flora Growth (FRA:7301) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Flora Growth Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Flora Growth Corp (FRA:7301) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

FLGC:USA 7301:Germany

Address

3406 South West 26th Terrace, Suite C-1, Fort Lauderdale, FL, USA, 33132

Website

https://www.floragrowth.com

Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.

Flora Growth Headlines

No Headlines